Fibroblast growth factor 23–secreting pancreaticobiliary malignancy
Journal of Onco-Nephrology · 2018
DOI: 10.1177/2399369318776177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Onco-Nephrology, 2018. Verfasst von Valerie Barta und 4 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
Malignancy-related tumor-induced osteomalacia is a rare but important entity. We report the first case of oncogenic renal phosphate wasting in the setting of a pancreaticobiliary malignancy. Our patient presented with refractory hypophosphatemia. Workup revealed high fibroblast growth factor 23 levels as well as a new pancreaticobiliary mass. All other causes of hypophosphatemia were ruled out. With tumor-induced osteomalacia, an accurate diagnosis and location of the offending tumor is essential for appropriate management and treatment.
Zitieren
APA
Barta, V., Lalkiya, N., Phan, H., Miller, I., & Sachdeva, M. (2018). Fibroblast growth factor 23–secreting pancreaticobiliary malignancy. Journal of Onco-Nephrology. https://doi.org/10.1177/2399369318776177
Vancouver
Barta V, Lalkiya N, Phan H, Miller I, Sachdeva M. Fibroblast growth factor 23–secreting pancreaticobiliary malignancy. Journal of Onco-Nephrology. 2018. doi:10.1177/2399369318776177
BibTeX
@article{Barta2018,
author = {Barta, Valerie and Lalkiya, Neel and Phan, Huy and Miller, Ilene and Sachdeva, Mala},
title = {Fibroblast growth factor 23–secreting pancreaticobiliary malignancy},
journal = {Journal of Onco-Nephrology},
year = {2018},
doi = {10.1177/2399369318776177}
}
EUVIMED